Ngenla® 24 mg & 60 mg solution for injection in pre-filled pen
*Company:
Pfizer Healthcare IrelandStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 25 March 2024
File name
Adv SPC NL 5_0 IE clean.pdf
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 25 March 2024
File name
Adv PIL NL 4_0 24mg IE NI clean.pdf
Reasons for updating
- Change to section 3 - how to take/use
- Change to section 6 - date of revision
Updated on 25 March 2024
File name
Adv PIL NL 4_0 60mg IE NI clean.pdf
Reasons for updating
- Change to section 3 - how to take/use
- Change to section 6 - date of revision
Updated on 26 October 2023
File name
Adv SPC NL 4_0 IE clean.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 5.1 - Pharmacodynamic properties
- Correction of spelling/typing errors
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 October 2023
File name
Adv PIL NL 3_0 24mg IE NI clean.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26 October 2023
File name
Adv PIL NL 3_0 60mg IE NI clean.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26 October 2023
File name
Adv PIL NL 3_0 24mg IE NI clean.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26 October 2023
File name
Adv PIL NL 3_0 60mg IE NI clean.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 13 December 2022
File name
AdvSPCNL30IEclean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 December 2022
File name
Adv PIL NL 2_0 24 mg IE NI clean.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to MA holder contact details
Updated on 01 December 2022
File name
Adv PIL NL 2_0 60 mg IE NI clean.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to MA holder contact details
Updated on 22 September 2022
File name
Adv PIL NL 1_0 24mg IE NI.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New PIL for New Product
Updated on 22 September 2022
File name
Adv PIL NL 1_0 60mg IE NI.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New PIL for New Product
Updated on 22 September 2022
File name
Adv SPC NL 2_0 IE.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SPC for New Product